Pocket ObGyn – Adenomyosis

Pocket ObGyn – Adenomyosis
See Abbreviations

Definition & Pathogenesis
  • Presence of endometrial glands & stroma w/i the uterine musculature
  • Amt & degree of invasion Diffuse or circumscribed focal glandular deposits.
Epidemiology
  • Unclear etiology, but several Possibly invagination of endometrium into myometrium, or misplaced stem cells or Müllerian remnants.
  • 70–80% of cases seen in 4th & 5th Only 5–25% of adenomyosis seen <39 yo.
  • Estrogen & progesterone likely play role in dev & Often develops during reproductive years & regresses after menopause. Risk factors: Parity, ­ age
Clinical Manifestations & Physical Exam Findings
  • Menorrhagia & Many asx. Severity correlates w/ ­ ectopic foci & extent of invasion. Less common complaints: Dyspareunia, CPP, infertility.
  • Ectopic endometrial tissue ® proliferates ® enlarged globular uterus on exam

Diagnostic Workup (J Minim Invasive Gynecol 2011;18:428)

  • Dx by histology. Uniform dx based on histology not yet
  • ­ Ca-125 levels may be seen, but not proven to be helpful in mgmt or
  • TVUS preferred imaging technique = ill-defined myometrial heterogeneity, may be myometrial cysts (round anechoic areas). MRI may be complementary = large asym uterus, thickened junctional zone (innermost myometrial layer), no
Treatment & Medications
  • No medical therapy exists at this time to treat sx while allowing pts to
  • Conservative, medical mgmt for symptomatic adenomyosis similar to 1° menorrhagia or Goal = temporarily induce regression of adenomyosis.
  • NSAIDs often May consider: Continuous oral contraceptives, progestins, Mirena IUD, danazol, & GnRH agonist.
  • Surgical Mgmt (J Minim Invasive Gynecol 2011;18:428):

Hysterectomy = Std rx option for those done w/ childbearing.

Endometrial ablation = Treats menorrhagia sx. Less successful if ­ penetration of adenomyosis into uterus is present.

UAE: Controversial. Less successful if fibroids also present.

Focal excision: Must be able to identify area, margins, & extent of dz. Low efficacy (50%). Addition of GnRH agonist ¯ relapse rates by 20% in 2 y. May have fertility & deliv implications depending on size & location of excision.

See Abbreviations